← Leaderboards
Deborah Slee
Aspyrian Therapeutics, Inc.
$663,221
Attributed
$1,020,280
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $603.7K · FY2011–16$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,020,280 · 3
By mechanism
R43$722,725 · 2
R44$297,555 · 1
Top collaborators
- Miguel Garcia-Guzman1 shared
- Ahmed Samatar1 shared
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsEvaluationDosePharmaceutical PreparationsSafetyApplications GrantsStandard Of CareMalignant NeoplasmsPreclinical StudyPharmacodynamicsIn VivoSeriesToxicologyTumorLeadPropertyFutureHandBaseMalignant Neoplasm Of PancreasPancreatic NeoplasmBiologicalBiodistributionArchitecture